
AML stands for Acute Myeloid Leukemia, a blood cancer that begins in the blood and the source of the blood, bone marrow, which deals with myeloid cells responsible for the generation of red blood cells, white blood cells, and platelets. With acute myeloid leukaemia, the bone marrow produces abnormal myeloblasts, immature white blood cells that do not mature properly, thus crowding normal cells. Therefore, a variety of symptoms and complications arise.
Preventing Disease Progression
AML is an aggressive cancer that can quickly progress if active treatment is not initiated, often leading to severe complications, organ dysfunctions, and even death.
Encourage Treatment Response
The earlier the therapy is initiated, the higher the chance of inducing remission and preventing relapse; failure to treat in a timely manner translates into poorer prognoses and decreased treatment effectiveness.
Complications are minimised
After treating AML at its earliest possible stage, resolving the issues of these complications is much more favourable, with an increased chance of avoiding any complications that can be life-threatening.
Good long-term prognosis
If treatment is started earlier, there is a better chance of long-term survival. Although AML remains hard to cure, if treatment is given aggressively after an early diagnosis, remission can be achieved.
Quality of life
An early start of management can help control a patient's symptoms like fatigue, pain, and infections, benefiting his quality of life during treatment.
Causes
Risk Factors
Amidst growing new drug entities for treating Acute Myeloid Leukemia (AML) inhibitors, the condition is reframed into better treatment outcomes within the genetically mutated population pipeline. CAR-T cell therapy is also considered a potential treatment for recurrent relapses, leveraging the induced immune response against leukemic cells. Another concept that plays a significant role in personalising treatment is next-generation sequencing (NGS), which identifies genetic abnormalities. Minimal Residual Disease (MRD) monitoring detects, after adequate treatment, traces of leukemia that a person may have experienced, thus reducing relapse chances. Stem cell transplants with reduced-intensity conditioning can expand the donor pool and improve survival chances. Immunotherapies and monoclonal antibodies are being investigated in clinical trials and are expected to bring renewed hope for many AML patients.
Avoiding exposure to harmful chemicals
Reducing exposure to toxic substances such as benzene (produced by petrochemical industries) and cigarette smoke may reduce the likelihood of developing AML. Provide protective equipment in high-risk workplaces to minimise exposure.
Limiting Exposure to Radiation
There are exposures which cannot be avoided, such as treatment with radiation from a pre-existing cancer diagnosis.
Healthy Lifestyle Choices
Adopting healthy meal plans, exercising, and not smoking will significantly reduce the risk of developing AML. A strong immune system is crucial in fighting infections and diseases, including leukemia.
Genetic Counselling Services for High-Risk Individuals
Genetic counselling is an option to consider if there is a family history of leukemia or inherited conditions like Down syndrome, Fanconi anemia, or Bloom syndrome. If there is, screening and early detection can solve the issues.
Regular Health Check-Ups
These regular health check-ups will lead to early diagnosis of blood disorders. Early diagnosis of diseases such as myelodysplastic syndromes (MDS) will ensure early treatment and reduce the risk of developing acute myeloid leukaemia (AML).
The medical treatment for Acute Myeloid Leukemia (AML) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Chemotherapy: The induction chemotherapy regimen typically begins when a patient is given cytarabine and idarubicin. There will then be consolidation chemotherapy offered to the affected individual to get rid of residual cells and minimise the risk of relapse.
Cost Start From USD 36600 - USD 0Explore Options
Stem Cell Transplantation : Bone marrow transplants (also known as stem cell transplants) offer the possibility of a cure for some patients with high-risk or relapsed forms of acute myeloid leukemia, replacing diseased marrow with healthy cells, thus improving long-term survival chances.
Cost Start From USD 5000 - USD 50000Explore Options
Targeted Therapy : Specific targeted drugs have been used to treat specific genetic mutations in the cells of patients with AML to enhance treatment benefits, particularly for those with mutations.
Cost Start From USD 10000 - USD 50000Explore Options
Immunotherapy : Emerging therapies such as immune checkpoint inhibitors (nivolumab and pembrolizumab) and CAR-T cell therapy have shown promise in using the immune system against leukemia cells for high-risk patients.
Cost Start From USD 9000 - USD 234000Explore Options
CAR-T (Chimeric Antigen Receptor T-cell) Therapy : AML is one of the most challenging conditions associated with CAR-T therapy because the antigens are not well-defined and are difficult to target. In any case, the selected groups are specific to targets on AML cells.
Cost Start From USD 475000 - USD 0Explore Options
These are the standard diagnostic methods for diagnosing Acute Myeloid Leukemia (AML):
Imaging Studies
Blood Tests
Bone Marrow Biopsy
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Physical Rehabilitation
Post-treatment exercise programs enhance patients' strength, mobility, and endurance, particularly after chemotherapy or stem cell transplant.
Occupational Therapy
Occupational therapists help patients restore their daily functioning activities, such as dressing and cooking. It also provides cognitive rehabilitation to help address memory and concentration issues that may arise from treatment.
Psychological Support
Counseling for mental health assists patients in coping with emotional challenges like anxiety and depression during and after treatment.
Lifestyle Modifications
The nutritionist assists patients with AML who are experiencing problems with losing weight due to a lack of appetite and malnutrition correction.
Pain and Fatigue Management
Pain treatment provides symptom control through medication or alternative means against pain caused by treatment. Features of chronic fatigue will be treated by conserving energy and regular rest to recuperate.









Novena, Singapore
Mount Elizabeth Novena Hospital located in Novena, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Singapore, Singapore
Parkway East Hospital located in Joo Chiat Pl, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Singapore, Singapore
Mount Elizabeth Hospital located in Singapore, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the growing reasons for Singapore being frequented for Pancreatic Neuroendocrine Tumor treatment:
While there is treatment available for AML, some patients can be cured, particularly with early detection and prompt action. The prognosis is influenced by several factors, including age, overall well-being, and the presence of any genetic mutations identified in the leukemic cells.
The prognosis depends on the patient's age, response to treatment, presence of genetic mutations, and whether the leukemia was acute or relapsed. Better treatment results are seen in younger patients with favorable mutations.
Treatment may cause fatigue, nausea and vomiting, loss of hair, infections, low blood counts, and organ toxicity. Long-term side effects primarily include heart, lung, and immune system dysfunction.
Although genetic mutations are a cause of AML, the vast majority of cases are not inherited. However, a family history of leukemia or other genetic syndromes can increase the risk of developing AML.
Singapore has advanced centers performing autologous and allogeneic stem cell transplants.
Yes, many Singaporean hospitals offer specialised services for international AML patients.
MRD testing helps detect tiny traces of leukemia after treatment and is widely used in Singapore.
Hospitals offer translation services, accommodation assistance, and specialised oncology care.
Patients are generally advised to follow a high-protein, high-calorie, balanced diet, maintain good hygiene to prevent infections, and manage stress effectively. Regular follow-up visits are essential to detect complications or relapse early.
Common complications of AML are infections, bleeding, and organ impairment owing to the low blood cell count. The significant complications, which could lead to respiratory or organ failure, are mostly experienced during intensive treatments like chemotherapy.
Stroke in Children : Rare But Real
Childhood stroke is uncommon but can have serious effects on kids, often leading to significant health challenges. The causes vary and differ from those seen in adults. There's still a lot to learn about strokes in children. It's crucial for doctors working with young patients to recognize the signs of a stroke at any age so they can provide appropriate care, helping the brain heal and function better.
Stroke is defined by the World Health Organization (WHO) as “a clinical syndrome consisting of rapidly developing clinical signs of focal (global in case of coma) disturbance of cerebral function lasting more than 24 hours or leading to death with no apparent cause other than a vascular origin.”
Type of stroke based on a child's age:
Perinatal stroke: It happens between 28 weeks of pregnancy and the first 28 days after birth. There are two main types within this category. Acute perinatal strokes occur right at or soon after birth and can show up as focal seizures or changes in consciousness. On the other hand, presumed perinatal strokes are chronic problems identified later on, believed to have happened during the earlier period.
Childhood stroke: which occurs from 28 days after birth up until the age of 18. Ischemic stroke in children happens in about 1 to 2 out of every 100,000 kids each year in developed Western countries. The risk is greatest for infants and kids under 5, and it affects boys more often than girls. Also, Black and Asian children tend to experience strokes more frequently than white children.
How common is stroke in children
Studies show there are about 1 to 2 cases of stroke for every 100,000 kids under 18 each year. For newborns, the rate is roughly 1 perinatal stroke for every 3,500 live births. It’s important to note that these figures can be tricky to pinpoint because diagnosing strokes can be quite difficult.
What are the risk factor in children for stroke
Risk factors include both maternal and neonatal factors. Normal activation of coagulation factors in the mother and low levels of factors in the infant just before and after the time of delivery may contribute to the increased stroke risk in neonates
Neonatal Risk Factors
Maternal Risk Factors
Common signs and symptoms of stroke in children
Various imaging tests diagnosing a stroke in children
Management of Stroke in Children:
Every kid's journey is different. It’s important to have a multidisciplinary team that includes an occupational and physical therapist, a speech therapist, a neuropsychologist, a social worker, school officials, and a nutritionist. Together, they make a customized recovery plan. After a child has a stroke, they might face challenges like weak muscles, tight muscles, difficulty swallowing, issues with thinking, or trouble speaking and balance.
Strokes in children are difficult to diagnose because the symptoms are often subtle, which means they can be easily misdiagnosed. It is really important to thoroughly check a child's neurological health, look at their symptoms, and use radiological tests for an accurate diagnosis. Getting this diagnosis quickly is crucial. When we do, it can lead to better long-term outcomes and reduce the risk of serious neurological issues that could develop if a stroke isn’t treated properly.